PB 73 of 2017

National Health Determination under paragraph 98C(1)(b) Amendment 2017
(No. 6)

_____________________________________________________________________

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 19 September 2017

JULIANNE QUAINE

First Assistant Secretary (Acting)

Technology Assessment and Access Division

Department of Health

1 Name of Instrument

(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2017 (No. 6).

(2)                This Instrument may also be cited as PB 73 of 2017.

2  Commencement  

  This instrument commences on 1 October 2017.

3  Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

  Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1 Amendments

[1]                 Schedule 3, entry for Oxycodone in the form Oral solution containing oxycodone hydrochloride 5 mg per 5 mL, 250 mL

omit from the column headed “Form (strength, type, size, etc.)”:

5 mg per 5 mL

substitute:

1 mg per mL